ArticleBone marrow transplantation2026
Early high-resolution immune profiles are associated with survival, relapse and graft-versus-host-disease after allogeneic hematopoietic cell transplantation.
Article in Bone marrow transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Allogeneic hematopoietic cell transplantation (allo-HCT) is a well-established treatment in several hematological malignancies, where post-transplant complications are largely immune-driven. Post-transplantation (post-HCT) immune status assessment is essential for clinical monitoring of patients. In this study, immune cell composition and function was evaluated in whole blood from 77 adult allo-HCT recipients taken day +28 post-transplantation. High-resolution immunophenotyping assessed innate and adaptive immune compartments, including activation and immune checkpoint markers, while cytokine release after stimulation with T cell or innate stimuli examined immune function. Improved survival was associated with increased immune cell counts of both innate and adaptive immune compartments, as well as elevated cytokine-release responses. Elevated myeloid and innate lymphoid subsets and innately stimulated cytokine release were also associated with lower relapse incidence. Increased CD4 T cell PD-1 expression and HLA-DR on CD8 T cells was associated with poorer overall survival. These findings emphasize the importance of early innate immune reconstitution, indicating that integrating functional and phenotypic profiling could reveal new information regarding cell subsets of interest for allo-HCT patient monitoring, as well as potential targets for immunomodulation or cell therapies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.